Not applicableStudy completedNCT03226951What this trial is testingSDM Laser for Non Central Diabetic CSMEWho this might be right forNon Central Diabetic Macular Edema Marashi Eye Clinic 8
Testing effectiveness (Phase 2)Study completedNCT00412451What this trial is testingStudy to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)Who this might be right forDiabetic Macular Edema ThromboGenics 51
Testing effectiveness (Phase 2)UnknownNCT01975103What this trial is testingNon-damaging Retinal Laser Therapy With PASCAL Laser for Macular DiseasesWho this might be right forDiabetic Macular EdemaBranch Retinal Vein OcclusionChronic Central Serous Retinopathy+1 more Federal University of Rio Grande do Sul 20
Testing effectiveness (Phase 2)Study completedNCT06599684What this trial is testingStudy of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyWho this might be right forNon-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic Retinopathy+2 more Invirsa, Inc. 19
Testing effectiveness (Phase 2)WithdrawnNCT03384524What this trial is testingEvaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DMEWho this might be right forDiabetic Macular Edema Andrew Moshfeghi, MD, MBA
Early research (Phase 1)Active Not RecruitingNCT06847854What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)Who this might be right forDiabetic Macular Edema Genentech, Inc. 151
Testing effectiveness (Phase 2)Study completedNCT01724554What this trial is testingImpact of Intravitreal Aflibercept Injections on Capillary Non-PerfusionWho this might be right forCentral Retinal Vein OcclusionProliferative Diabetic Retinopathy Ophthalmic Consultants of Boston 24
Post-approval studies (Phase 4)Study completedNCT02834663What this trial is testingEffects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic RetinopathyWho this might be right forNonproliferative Diabetic Retinopathy Wonkwang University Hospital 25
Post-approval studies (Phase 4)Study completedNCT02472366What this trial is testingA Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid TherapyWho this might be right forChronic Diabetic Macular Edema Alimera Sciences 16
Testing effectiveness (Phase 2)Study completedNCT01331005What this trial is testingNSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)Who this might be right forDiabetic Macular Edema Jaeb Center for Health Research 125
Post-approval studies (Phase 4)Study completedNCT06591598What this trial is testingLearn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular DegenerationWho this might be right forDiabetic Macular EdemaNeovascular Age-related Macular Degeneration Bayer 51
Testing effectiveness (Phase 2)Study completedNCT02314299What this trial is testingMTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular DegenerationWho this might be right forDiabetic Macular EdemaAge-related Macular Degeneration Stealth BioTherapeutics Inc. 20
Not applicableLooking for participantsNCT07038967What this trial is testingNon-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After PhacoemulsificationWho this might be right forNon-CenterDiabetic Macular EdemaPhacoemulsification Ain Shams University 50
Testing effectiveness (Phase 2)Study completedNCT04552600What this trial is testingStudy to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.Who this might be right forDiabetic Retinopathy Natureceuticals Sdn Bhd 100
Testing effectiveness (Phase 2)Study completedNCT00284050What this trial is testingSafety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center InvolvementWho this might be right forDiabetic Macular Edema Novartis 151
Early research (Phase 1)Study completedNCT06771271What this trial is testingInvestigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular EdemaWho this might be right forDiabetic Macular EdemaUveitic Macular Edema Hoffmann-La Roche 85
Not applicableStudy completedNCT01771081What this trial is testingEvaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF TherapyWho this might be right forOphthalmologyMacular EdemaMacular Degeneration Bayer 911
Not applicableStudy completedNCT01638858What this trial is testingTreatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)Who this might be right forAge-Related Macular Degeneration University of Luebeck 25
Testing effectiveness (Phase 2)Study completedNCT03238963What this trial is testingA Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.Who this might be right forDiabetic Retinopathy Boehringer Ingelheim 79